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tients with Dent’s disease. Endocytosis and processing of 
LMW proteins involve the multiligand tandem receptors, 
megalin and cubilin, that are abundantly expressed at the 
brush border of PT cells. Characterization of the endocytic 
defect in ClC-5 KO mice revealed that ligands of both mega-
lin and cubilin were affected. The total kidney content of 
megalin and especially cubilin at the protein level was de-
creased but, more importantly, using analytical subcellular 
fractionation and quantitative immunogold labelling we 
demonstrated a selective disappearance of megalin and cu-
bilin at the brush border of PT cells. These observations al-
lowed us to conclude that defective protein endocytosis 
linked to ClC-5 inactivation is due at least in part to a major 
and selective loss of megalin and cubilin at the brush bor-
der, refl ecting a traffi cking defect in renal PT cells. These 
results improve our understanding of Dent’s disease, taken 
as a paradigm for renal Fanconi syndrome and nephroli-
thiasis, and demonstrate multiple roles for ClC-5 in the kid-
ney. These studies also provided insights into important 
functions such as apical endocytosis, handling of proteins 
by renal tubular cells, calcium metabolism, and urinary 
acidifi cation. 
 Copyright © 2005 S. Karger AG, Basel 
 Introduction 
 Kidney stones (nephrolithiasis) represent a major 
health problem as they affect more than 10% of males and 
5% of females by the age of 70 years and are often com-
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 Abstract 
 Dent’s disease is a hereditary renal tubular disorder char-
acterized by low-molecular weight (LMW) proteinuria, hy-
percalciuria and nephrolithiasis. The disease is due to mu-
tations of ClC-5, a member of the family of voltage-gated 
CLC chloride channels. ClC-5 is expressed in part in cells 
lining the proximal tubule (PT) of the kidney, where it colo-
calizes with albumin-containing endocytic vesicles belong-
ing to the receptor-mediated endocytic pathway that en-
sures effi cient reabsorption of ultrafi ltrated LMW proteins. 
Since progression along the endocytic apparatus requires 
endosomal acidifi cation, it has been suggested that dys-
function of ClC-5 in endosomes may lead to ineffi cient re-
absorption of LMW proteins and dysfunction of PT cells. 
Analysis of a ClC-5 knockout (KO) mouse model, displaying 
all the characteristic renal tubular defects of Dent’s disease, 
showed evidence of a severe LMW proteinuria. Cytochem-
ical studies with the endocytic tracer, peroxidase, showed 
poor transfer into early endocytic vesicles, suggesting that 
impairment of receptor-mediated endocytosis in PT cells is 
the basis for the defective uptake of LMW proteins in pa-
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plicated by nephrocalcinosis and renal failure. Nephroli-
thiasis occurs as an inherited disorder in about half the 
patients and is most commonly associated with hypercal-
ciuria. The biochemical basis for hereditary nephrolithia-
sis and hypercalciuria is unknown, which has hampered 
therapeutic developments  [1] . 
 Recent genetic studies have provided important clues 
to the understanding of nephrolithiasis. Three disorders 
of hypercalciuric nephrolithiasis (Dent’s disease and its 
variants X-linked recessive nephrolithiasis and X-linked 
recessive hypophosphatemic rickets) have been mapped 
to Xp11.22  [2] . These disorders are characterized by a 
dysfunction of the renal proximal tubule (PT; renal Fan-
coni syndrome), with low-molecular weight (LMW) pro-
teinuria, hypercalciuria, nephrocalcinosis, nephrolithiasis 
and renal failure  [3] . A search for renally expressed genes 
from this region identiﬁ ed inactivating mutations of 
 CLCN5 , a member of the CLC family of voltage-gated 
chloride channels, in Dent’s disease and its variants  [4] . 
Despite these genetic advances, the mechanisms whereby 
the loss of a chloride channel leads to hypercalciuria and 
renal tubular defects remain unknown. 
 This review describes a series of molecular investiga-
tions that allowed us to investigate the pathophysiology of 
Dent’s disease taken as a paradigm of renal tubular disease 
and nephrolithiasis. These studies provided new insights 
into the role of chloride channels in apical endocytosis and 
renal tubular handling of proteins, calcium and protons. 
 Intrarenal and Subcellular Distribution of
ClC-5 Suggests a Pathophysiological Basis
for Dent’s Disease 
 CLCN5 belongs to the CLC family of voltage-gated 
chloride channel genes, of which nine different members 
have been identiﬁ ed in mammals. These chloride chan-
nels are important for the control of membrane excitabil-
ity, transepithelial transport, and possibly regulation of 
cell volume  [5] .  CLCN5 is predominantly expressed in the 
kidney. It encodes ClC-5, a 746-amino acid protein that 
induces strong outwardly rectifying chloride currents in 
heterologous expression systems. These currents are mark-
edly reduced or abolished by mutations of Dent’s disease 
 [3–5] . 
 In order to understand how the loss of the chloride 
channel ClC-5 leads to multiple renal tubular defects, we 
analyzed the segmental and subcellular expression of
ClC-5 in the kidney  [6] . Immunoblotting studies identi-
ﬁ ed the ~80-kDa ClC-5 in human kidney cortex and
medulla. Immunohistochemistry revealed ClC-5 expres-
sion in epithelial cells lining the PT, the thick ascending 
limb (TAL) of Henle’s loop, and the intercalated cells (ICs) 
of the collecting ducts. Analytical subcellular fraction-
ation of the human kidney suggested that ClC-5 colocal-
izes with the vacuolar H + -ATPase and is associated with 
markers of early endosomes (Rab 5a). Confocal micros-
copy studies using opossum kidney (OK) cells, a model for 
PT cells, conﬁ rmed that ClC-5 colocalized with albumin-
containing endocytic vesicles that form part of the recep-
tor-mediated endocytic pathway  [6] . 
 Taken together, these studies indicated that the expres-
sion of ClC-5 in multiple nephron segments could explain 
the complex phenotype of Dent’s disease. A loss of ClC-5 
function in the TAL, which is a major site of regulated 
calcium reabsorption, may result in hypercalciuria. Since 
the reabsorption of LMW proteins is restricted to the PT 
and involves endocytosis with subsequent transport to the 
acidic vacuolar-lysosomal system, dysfunction of ClC-5 in 
PT endosomes may impair endosomal acidiﬁ cation and 
lead to inefﬁ cient reabsorption of LMW proteins and dys-
function of PT cells. 
 Characterization of a ClC-5 Knockout Mouse 
Model for Dent’s Disease 
 Dent’s disease is thus characterized by PT defects that 
include LMW proteinuria, and usually aminoaciduria and 
glycosuria, together with hypercalciuria and nephrocalci-
nosis. In order to better understand the roles of
ClC-5 and the pathophysiology of Dent’s disease, we char-
acterized a ClC-5 knockout (KO) mouse obtained by ho-
mologous recombination targeting exon VI of  Clcn5  [7] . 
The KO  mice were viable at birth and showed normal 
growth and survival. Northern and Western blot analyses 
conﬁ rmed the absence of ClC-5 in the kidneys of KO mice. 
Mice lacking ClC-5 developed renal tubular defects, which 
included LMW proteinuria, aminoaciduria, glycosuria, 
phosphaturia and polyuria. They also developed hypercal-
ciuria and nephrocalcinosis, while progressive renal fail-
ure was observed with aging. Further investigations indi-
cated that the hypercalciuria in the ClC-5 KO mice is of 
bone and renal origin, and is not caused by increased in-
testinal calcium absorption – despite elevated levels of 
1  ,25-dihydroxyvitamin D3  [8] . 
 LMW proteins ( ! 70 kDa) are normally ﬁ ltered at the 
glomerulus and avidly recaptured by receptor-mediated 
endocytosis in PT cells. ClC-5 has been localized to early 
endosomes belonging to this pathway  [6] . In order to study 
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this process more closely, mice were injected with peroxi-
dase, a classical endocytic tracer that is ﬁ ltered by the 
glomerulus and endocytosed by PT cells. Cytochemistry 
and electron microscopy showed a severe impairment of 
protein endocytosis by PT cells in ClC-5 KO mice, so that 
peroxidase bound to the brush border was poorly trans-
ferred into early endocytic vesicles  [7] . These data, which 
were conﬁ rmed in another mouse model  [9] , demonstrat-
ed that impairment of receptor-mediated endocytosis in 
PT cells of  Clcn5 -deﬁ cient mice provides a basis for the 
defective uptake and increased urinary excretion of LMW 
proteins. 
 Loss of ClC-5 Impairs Endocytosis by Defective 
Traffi cking in Kidney Proximal Tubules 
 The endocytosis and processing of LMW proteins in-
volve the multiligand tandem receptors, megalin and cu-
bilin, that are abundantly expressed at the brush border 
of PT cells  [10] . Megalin, the largest member of the LDL 
receptor family, interacts with cubilin and both receptors 
are internalized together. Diseases of PT cells, collective-
ly called renal Fanconi syndromes, are all characterized 
by LMW proteinuria. This is reproduced in megalin KO 
mice and cubilin-defective dogs  [10] . 
 Since progression along the endocytic apparatus de-
pends on endosomal acidiﬁ cation, the defective endocy-
tosis observed in Dent’s disease  [4] and ClC-5 KO mice 
 [7, 9] has been attributed to impaired endosomal acidiﬁ -
cation secondary to loss of chloride permeability. How-
ever, drugs abrogating vacuolar acidiﬁ cation do not affect 
the rate of endocytic uptake, but inhibit recycling or arrest 
transfer to lysosomes  [11] . We therefore looked for a more 
speciﬁ c alteration along the endocytic pathway in Dent’s 
disease, i.e. a lack of the essential components, megalin 
and cubilin, at the brush border. To this aim, we exten-
sively characterized the endocytic defect in ClC-5 KO 
mice and found that ligands of both megalin and cubilin 
were affected. Next, we showed a decrease in total kidney 
content of megalin and cubilin at the protein level but not 
at the mRNA level. Finally, using analytical subcellular 
fractionation and quantitative immunogold labelling, we 
demonstrated a selective disappearance of megalin and 
cubilin at the brush border of PT cells. These observations 
allowed us to conclude that defective protein endocytosis 
linked to ClC-5 inactivation is due to a major and selec-
tive loss of megalin and cubilin at the brush border, reﬂ ect-
ing a trafﬁ cking defect in renal PT cells  [11] . 
 Altered Polarity and Expression of H + -ATPase 
without Ultrastructural Changes in Kidneys of 
Dent’s Disease Patients 
 Our initial studies have shown that ClC-5 colocalizes 
with the vacuolar H + -ATPase in PT cells and ICs  [6] . Stud-
ies of KO mice  [7] have established the role of ClC-5 in 
PT endocytosis, but the consequences of ClC-5 mutations 
on the human kidney remained unknown. 
 We have established a multicentric database of renal 
biopsies from patients with Dent’s disease and document-
ed inactivating ClC-5 mutations  [12] . Light microscopy 
revealed a normal renal architecture or glomerulosclero-
sis, tubular dedifferentiation, and mild interstitial ﬁ bro-
sis. Renal calciﬁ cations were identiﬁ ed at all stages. De-
spite the generalized PT dysfunction, electron microscopy 
did not reveal any ultrastructural abnormalities in PT 
cells, and the endocytic apparatus was normal. However, 
immunohistochemistry studies demonstrated a consistent 
inversion of H + -ATPase polarity in PT cells to a basolat-
eral distribution contrasting with its apical location in the 
normal kidney. This inversion of polarity was speciﬁ c and 
did not affect distribution of aminopeptidase, megalin or 
Na + -K + -ATPase. Furthermore, apical H + -ATPase expres-
sion was absent in   -type intercalated cells  [12] . These 
modiﬁ cations in polarity and/or expression of the H + -
ATPase point to an interaction between the C-terminus 
of ClC-5 and H + -ATPase that would be essential for the 
proper targeting or stability of the latter. These data are 
important in the investigation of molecular interactions 
involving ClC-5 and help us to understand some aspects 
of Dent’s disease, namely the deﬁ cit in urinary acidiﬁ ca-
tion observed in some patients  [3] . 
 Comparative Ontogeny and Segmental 
Distribution of ClC-5 
 The clinical manifestations of Dent’s disease often oc-
cur during childhood, and LMW proteinuria is a consis-
tent feature of the disease. In particular, the early onset 
of some cases, in which tubular proteinuria was discov-
ered in the ﬁ rst month of life  [13] , suggests that segmen-
tal expression of ClC-5 in PT must be acquired before 
birth. We have recently investigated the ontogeny of
ClC-5, and its processing and segmental distribution dur-
ing nephrogenesis  [14] . These studies showed that ClC-5 
undergoes a rapid induction at an early stage of mouse 
nephrogenesis, followed by a progressive maturation dur-
ing late nephrogenesis. Studies with the enzyme PGNase 
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F conﬁ rmed the early N-linked glycosylation of ClC-5, 
and the progressive maturation of the core protein during 
nephrogenesis. The distribution of ClC-5 in PT and   -
type IC, and its colocalization with H + -ATPase at these 
locations, are already achieved at embryonic day (E) 
15.5. In human nephrogenesis, ClC-5 is detected early 
during the second trimester, with a distribution that in-
cludes developing PT cells and, later, IC. These results 
complete early observations that the apical expression of 
brush border components and the distribution of megalin 
to the apical clathrin-coated membrane domains and en-
dosomes coincide with the onset of glomerular ﬁ ltration 
in rats  [15] . The coexpression of ClC-5 and H + -ATPase 
in PT cells immediately after initiation of glomerular ﬁ l-
tration could thus indicate the progressive maturation of 
renal tubular function and explain the decrease in the 
concentration of LMW proteins in the amniotic ﬂ uid dur-
ing gestation  [16] , as well as the early phenotypic variants 
of Dent’s disease  [13] . 
 In addition to PT cells, ClC-5 and H + -ATPase are co-
detected from E15.5 in mouse in the apical area of   -type 
IC  [14] . In human nephrogenesis, isolated cells positive 
for carbonic anhydrase type II (CAII) are identiﬁ ed with-
in ureteric buds and medullary collecting ducts (CDs) at 
15 gestation weeks (GW), and rare, isolated cells positive 
for H + -ATPase are identiﬁ ed at 19 GW. In contrast,
ClC-5 could not be identiﬁ ed in IC before 24 GW. The 
colocalization of ClC-5 with CAII and/or H + -ATPase in 
IC was only observed postnatally, conﬁ rming data ob-
tained in mature kidney  [6] . These results suggest species 
differences in the maturation of IC  [17] and support the 
hypothesis that, in humans, the differentiation of IC oc-
curs later than that of the principal cells of the CD  [18] . 
 Recent Developments and Perspectives 
 Recent developments in the molecular genetics and 
pathophysiology of Dent’s disease should be pointed out. 
Crucially important information is the demonstration 
that Dent’s disease is genetically heterogeneous. In a care-
ful analysis, Hoopes et al.  [19] were unable to ﬁ nd muta-
tions in the coding sequence and promoter regions of 
 CLCN5 in 13 of 32 unrelated patients meeting the clinical 
criteria for the disease. Furthermore, they excluded link-
age to the  CLCN5 region in a three-generation family  [19] . 
These data suggest that mutations in genes different from 
 CLCN5 can be involved in Dent’s disease. These genes 
presumably code for proteins that interact, directly or in-
directly, with ClC-5. For instance, an interaction between 
the C-terminus of ClC-5 and coﬁ lin, a protein involved in 
the depolymerization of actin in the immediate vicinity 
of endosomes, has been documented in cultured cells of 
PT origin  [20] . This could be crucial for mediating uptake 
of LMW proteins by PT cells. 
 In addition to genetic heterogeneity, mutation analysis 
has provided valuable information relating to the struc-
ture of ClC-5. The X-ray crystal structures of two bacte-
rial CLC proteins at 3.0-Å resolution have recently been 
established  [21] , conﬁ rming the prediction that the CLC 
channels are homodimers with a double-barreled conﬁ gu-
ration. Each subunit has its own pore and 17   -helices 
inserted into the plasma membrane, with an anti-parallel 
orientation that brings together residues responsible for 
anion selectivity  [21] . Based on these data, a model for 
human ClC-5 has been established, allowing analysis of 
the role of 15 non-truncating mutations (14 missense and 
one in-frame deletion) of  CLCN5  [22] . This analysis re-
vealed that none of these mutations involves the selectiv-
ity ﬁ lter, but that most of them (12/15) are clustered at the 
interface of the two subunits of the homodimeric channel 
 [22] . The functional evaluation of other naturally occur-
ring mutants is necessary in order to deﬁ ne the role of 
conserved domains for ClC-5 function and/or trafﬁ cking: 
a case in point is a C-terminus internalization motif, re-
sembling the PY motif that is essential for the internaliza-
tion and degradation of the epithelial sodium channel, 
ENaC  [23] . 
 In addition to PT and IC cells, ClC-5 is expressed in 
the TAL of Henle’s loop  [6] , but its role in this segment 
remains unclear. However, recent data obtained in a cul-
tured TAL murine cell line, as well as in mice exposed to 
water deprivation, suggest that exposure to hypertonicity 
upregulates the expression of ClC-5 at the mRNA and 
protein levels. Thus, the regulation of ClC-5 expression 
may be crucial for the adaptation to a hypertonic environ-
ment and the preservation of correct endocytic activity/
targeting in TAL cells  [24] . 
 A central hypothesis is that ClC-5 provides the chloride 
conductance necessary for endosomal acidiﬁ cation by the 
electrogenic vacuolar H + -ATPase  [7, 9, 25] . Based on de-
creased ATP-dependent ﬂ uorescence quenching of low-
density vesicles isolated from ClC-5 KO mice loaded in 
vitro by acridine orange, preliminary data from Gunther 
et al.  [26] support this view. However, these vesicles were 
not characterized as early endosomes (the well-document-
ed trafﬁ cking defect in the PT cells of ClC-5 KO mice may 
impair their puriﬁ cation and yield contamination by non-
endocytic acidiﬁ ed organelles), and the residual quench-
ing in these KO vesicles still showed chloride dependence 
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 [26] . In other words, a crucial role of ClC-5 in endosomal 
acidiﬁ cation remains to be proven. 
 Conclusions 
 The studies outlined here have provided critical infor-
mation to understand the pathophysiology of Dent’s dis-
ease, taken as a paradigm for renal Fanconi syndrome and 
nephrolithiasis. The characterization of the cellular and 
subcellular distribution of ClC-5 and detailed investiga-
tions in the ClC-5 KO mouse have demonstrated multiple 
roles for this chloride channel in the kidney. These studies 
also provided novel insights into essential functions such 
as apical endocytosis, handling of proteins by renal tubu-
lar cells, calcium metabolism, and urinary acidiﬁ cation. 
This information and the validation of a mouse model 
that harbors essential traits such as hypercalciuria and 
nephrocalcinosis should now prove useful in the develop-
ment of therapeutic strategies relevant for Dent’s disease, 
renal Fanconi syndromes and kidney stones. 
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